Drug intelligence / Profile preview

felis catus dander + felis catus skin

Development stage
Approved
Lead developer
Stallergenes Greer
Modality
Recombinant Proteins and Enzymes
Administration
Subcutaneous, Intradermal, Topical
01

Overview

Felis catus dander + felis catus skin is a **standardized allergenic extract biologic** composed of extracts from domestic cat dander and skin derived from cat pelt, marketed by Greer Laboratories for diagnostic skin testing and allergen immunotherapy in cat-allergic patients. The major clinically relevant allergen in the preparation is **Fel d 1**, which binds allergen-specific **IgE** on mast cells and basophils; in diagnostic use it provokes an immediate hypersensitivity response, while in immunotherapy repeated subcutaneous administration is intended to induce immune tolerance and reduce sensitivity to cat hair allergens. It is used for patients with cat allergy-associated allergic rhinitis, conjunctivitis, and allergic asthma when avoidance is not feasible, and is supplied as a sterile standardized solution.

Brand names
Standardized Cat Hair Allergenic Extract
Other names
cat hair allergenic extractstandardized cat pelt extractstandardized cat dander extractfelis catus dander + felis catus skin extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on felis catus dander + felis catus skin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on felis catus dander + felis catus skin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call